These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 36294946)
1. Microbiome in Chronic Kidney Disease. Tourountzis T; Lioulios G; Fylaktou A; Moysidou E; Papagianni A; Stangou M Life (Basel); 2022 Sep; 12(10):. PubMed ID: 36294946 [TBL] [Abstract][Full Text] [Related]
2. The Impact of CKD on Uremic Toxins and Gut Microbiota. Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343 [TBL] [Abstract][Full Text] [Related]
3. Link between gut microbiota dysbiosis and chronic kidney disease. Noce A; Marchetti M; Marrone G; Di Renzo L; Di Lauro M; Di Daniele F; Albanese M; Di Daniele N; De Lorenzo A Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2057-2074. PubMed ID: 35363356 [TBL] [Abstract][Full Text] [Related]
4. The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial. Ebrahim Z; Proost S; Tito RY; Raes J; Glorieux G; Moosa MR; Blaauw R Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215453 [TBL] [Abstract][Full Text] [Related]
11. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization. Filipska I; Winiarska A; Knysak M; Stompór T Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096 [TBL] [Abstract][Full Text] [Related]
12. Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients. Bao M; Zhang P; Guo S; Zou J; Ji J; Ding X; Yu X Front Cell Infect Microbiol; 2022; 12():639624. PubMed ID: 36237423 [TBL] [Abstract][Full Text] [Related]
13. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis. Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach. Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122 [TBL] [Abstract][Full Text] [Related]
15. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease. Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112 [TBL] [Abstract][Full Text] [Related]
16. Homeostasis in the Gut Microbiota in Chronic Kidney Disease. Bhargava S; Merckelbach E; Noels H; Vohra A; Jankowski J Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287917 [TBL] [Abstract][Full Text] [Related]
17. Potential Trimethylamine (TMA)-Producing Bacteria in patients with chronic kidney disease undergoing hemodialysis. Alvarenga L; Kemp JA; Schultz J; Cardozo LFMF; Nakao LS; Ribeiro-Alves M; Rosado A; Mafra D Int Urol Nephrol; 2024 Aug; ():. PubMed ID: 39215854 [TBL] [Abstract][Full Text] [Related]
18. Gut Microbiome and Microbiome-Derived Metabolites in Patients with End-Stage Kidney Disease. Koshida T; Gohda T; Sugimoto T; Asahara T; Asao R; Ohsawa I; Gotoh H; Murakoshi M; Suzuki Y; Yamashiro Y Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511232 [TBL] [Abstract][Full Text] [Related]
19. The Association between Gut Microbiota and Uremia of Chronic Kidney Disease. Kim JE; Kim HE; Park JI; Cho H; Kwak MJ; Kim BY; Yang SH; Lee JP; Kim DK; Joo KW; Kim YS; Kim BS; Lee H Microorganisms; 2020 Jun; 8(6):. PubMed ID: 32560104 [TBL] [Abstract][Full Text] [Related]